ANUH PHARMA LIMITED
ANNUAL REPORT 2011-2012
It is a pleasure to share my thoughts with you as we present our 52nd
Annual Report for Anuh Pharma Limited. Anuh Pharma Limited has been an
integral part of the SK Group. This year, the SK Group completes 80 years
of service to the pharmaceutical industry. The group was founded way back
in 1932, and has evolved over these eight decades as a leading importer,
exporter, distributor and manufacturer of bulk drugs, chemicals and
Anuh Pharma Limited has delivered yet another outstanding performance for
the year 2011-12. What makes this performance especially outstanding is the
fact that it was achieved at a time when the macro-environment was
difficult due to overall uncertainty in Eurozone, modest recovery in the US
and slowing growth in India.
The global pharmaceutical industry has been growing at the rate of 7%.
While R & D and innovations within the industry are still majorly dominated
by MNCs based in the western world, the manufacturing focus has been
shifting to Asian giants-China and India. China continues to remain the
biggest manufacturing centre followed by Italy and India, and it is
estimated that India will emerge as the second largest manufacturing hub in
2012, overtaking Italy.
The Indian pharmaceutical industry has been growing steadily at 14% for the
last 3 years. What has been noteworthy is the rapid upgradation in the
standards and quality of manufacturing. Indeed, one of the primary reasons
why more and more manufacturers are shifting to India is due to this rapid
scale up in plant, machinery and processes that match international
Another area where the Indian pharmaceutical industry has made significant
advances has been in R&D. R&D forms a critical part of this industry as new
products and new processes lend a substantial advantage.
At Anuh Pharma Limited, we have acquired assets of a Spanish R&D
laboratory. The acquisition of the R&D laboratory will further add to the
strengths of the company as well as to the overall strength of the Group.
As we move forward, we are confident that Anuh Pharma Limited will continue
MI to play a dominant role in the Indian pharmaceutical and API space and
keep building on the momentum and deliver yet better results.
Jayantilal P. Shah